(Ivanhoe Newswire) - Obstructive sleep apnea or OSA affects nearly a billion ... also known as Mounjaro or Zepbound. “It’s called GLP one receptor,” said Atul Malhotra, MD from the UC ...

Zepbound, a brand-name version of tirzepatide ... In 2024, the FDA also green-lit it to treat moderate to severe sleep apnea. How Much Do the Vials Cost Now? A four-week supply of a 2.5 mg ...

Presiding over the upward trajectory of Eli Lilly over the last eight years is paying off nicely for CEO David Ricks. | ...

ResMed has launched a rebrand to unify its portfolio and reflect its increasing direct-to-consumer engagement.

Indianapolis-based Eli Lilly and Co. launched LillyDirect a little more than a year ago and has been ramping up efforts to ...

The makers of two popular weight-loss drugs—Wegovy and Zepbound—are cutting prices to make the medications more affordable for people without insurance. Novo Nordisk, the Danish company behind Wegovy, ...

People with obstructive sleep apnea have an increased risk of Parkinson's disease, but if started early enough, continuous ...

Commercial insurance coverage of blockbuster GLP-1 drugs has not expanded much over the past year, despite growing demand and expanded indications, according to a new report from GoodRx. Data from ...